Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$531,594
+$13,466 QoQ
Shares Held
3,392
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#860
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Round Hill Asset Management holds $42,939,237 across 7 Drug Manufacturers - General names. NVS ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
37,380 | $13,536,045 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,350 | $9,168,475 | |
| 3 | NVO |
Novo Nordisk A S
|
122,031 | $5,850,166 | |
| 4 | PFE |
Pfizer Inc
|
242,134 | $5,830,586 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,646 | $4,128,242 | |
| 6 | ABBV |
AbbVie Inc.
|
15,475 | $3,894,129 | |
| 7 | NVS |
Novartis AG
This page
|
3,392 | $531,594 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $531,594 | 3,392 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $518,128 | 3,392 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $467,655 | 3,392 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $434,990 | 3,392 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $410,465 | 3,392 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $378,140 | 3,392 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $330,075 | 3,392 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $390,147 | 3,392 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $361,112 | 3,392 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $328,108 | 3,392 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $342,490 | 3,392 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $345,509 | 3,392 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $357,423 | 3,542 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $325,864 | 3,542 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $321,330 | 3,542 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $276,828 | 3,642 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $307,858 | 3,642 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $319,585 | 3,642 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $318,565 | 3,642 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $297,842 | 3,642 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $332,296 | 3,642 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $311,318 | 3,642 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $343,914 | 3,642 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $316,708 | 3,642 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $335,560 | 3,842 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $316,772 | 3,842 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||